The effects of neuropeptide Y on myocardial contractility and coronary blood flow
Open Access
- 1 September 1991
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 104 (1) , 195-201
- https://doi.org/10.1111/j.1476-5381.1991.tb12407.x
Abstract
This study was designed to assess the effects of exogenous neuropeptide Y (NPY) on cardiac contractility and coronary blood flow (CBF) in anaesthetized dogs and to evaluate the effect of NPY on the responses to sympathetic and parasympathetic stimulation and to inotropic agents. Bolus doses of NPY (500 μg), administered via the femoral vein, increased mean arterial pressure. The pressor effect was associated with reductions in heart rate, CBF and cardiac contractility. The effects of NPY (500 μg) on contractility and CBF were compared with that of vasopressin (VP) (1 unit). For similar reductions in CBF, NPY and VP had similar negative inotropic effects. Thus, it is likely that the negative inotropic response to NPY is not due to a direct effect of NPY on the heart muscle but is largely due to coronary vasoconstriction. In the presence of NPY (500 μg, i.v.), there was an inhibition of the positive inotropic response to stimulation of the left cardiac sympathetic nerve (2 or 5 Hz, 0.05 ms). NPY also inhibited the negative inotropic response and chronotropic response to vagal stimulation (2, 3 or 5 Hz, 0.05 ms). Dose‐response curves were obtained for the inotropic, chronotropic and pressor responses to cumulative infusions of noradrenaline (n = 6) and dobutamine (n = 6). NPY had no effect on these dose‐response curves. The effect of NPY on the responses to salbutamol and impromidine was assessed. NPY did not alter the positive inotropic, chronotropic or depressor responses to these agonists. Our results indicate that NPY has direct, postsynaptic vasoconstrictor activity and the reduction in myocardial contractility and heart rate are due to a combination of coronary vasoconstriction, baroreceptor reflex activation and presynaptic inhibition of transmitter release from sympathetic nerves. The well‐documented inhibitory effect of NPY on the chronotropic response to parasympathetic stimulation was confirmed and similar inhibition of the inotropic response to both sympathetic and parasympathetic stimulation was demonstrated. Since there was no modulation of the inotropic effects of exogenous α‐ and β‐ adrenoceptor or H2‐receptor agonists, it is concluded that the effects of NPY on myocardial contractility are exerted presynaptically.Keywords
This publication has 35 references indexed in Scilit:
- Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.Journal of Clinical Investigation, 1989
- EFFECTS OF NEUROPEPTIDE Y ON LEFT VENTRICULAR FUNCTION IN THE CONSCIOUS RABBITClinical and Experimental Pharmacology and Physiology, 1987
- Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).Japanese Heart Journal, 1987
- Neuropeptide Y (NPY) and the pig heart: Release and coronary vasoconstrictor effectsPeptides, 1986
- Studies on cardiac distribution and function of neuropeptide YActa Physiologica Scandinavica, 1986
- Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.Japanese Circulation Journal, 1985
- Neuropeptide Y (NPY) depresses the secretion of 3H‐noradrenaline and the contractile response evoked by field stimulation, in rat vas deferensActa Physiologica Scandinavica, 1984
- Neuropeptide Y And Noradrenaline Interaction in Peripheral Cardiovascular ControlClinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- The Cardiovascular Effects of Neuropeptide Y (NPY)Clinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- Positive Chronotropic and Negative Inotropic Actions of Vasopressin in Isolated Blood-Perfused Canine AtriumJapanese Heart Journal, 1977